ammonium hydroxide has been researched along with Sarcopenia in 13 studies
azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarcopenia has a negative impact on the prognosis of patients with liver cirrhosis (LC)." | 5.56 | Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis. ( Abe, K; Fujita, M; Hayashi, M; Ohira, H; Takahashi, A, 2020) |
| "Sarcopenia is a crucial factor in assessing the nutritional status of chronic liver disease patients and predicting their prognosis and survival." | 3.01 | [Sarcopenia in Chronic Liver Disease]. ( Seo, KI, 2023) |
| "Sarcopenia was positively associated with the presence of HE (OR 2." | 2.61 | Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. ( Chang, KV; Chen, JD; Han, DS; Huang, KC; Lin, HY; Wu, WT, 2019) |
| "Sarcopenia is a common complication of cirrhosis with a negative impact on posttransplant outcome, health-related quality of life (HRQOL), and patient survival." | 2.61 | L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle. ( Butterworth, RF, 2019) |
| "Sarcopenia has a negative impact on the prognosis of patients with liver cirrhosis (LC)." | 1.56 | Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis. ( Abe, K; Fujita, M; Hayashi, M; Ohira, H; Takahashi, A, 2020) |
| "Psychometric Hepatic Encephalopathy Score (PHES) and ammonia improved significantly in the patients with amelioration in SMI >10% (n = 16) and not in those without (n = 11) (PHES: -1." | 1.51 | The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. ( Gioia, S; Lattanzi, B; Merli, M; Nardelli, S; Pitocchi, F; Ridola, L; Riggio, O, 2019) |
| "Hepatic encephalopathy was defined by either a hepatic encephalopathy-related hospitalization and/or taking ammonia-lowering treatment (i." | 1.48 | Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. ( Bhanji, RA; Duarte-Rojo, A; Ebadi, M; Ghosh, S; Moctezuma-Velazquez, C; Montano-Loza, AJ; Rose, C, 2018) |
| "Sarcopenia is recognized as a condition related to quality of life and prognosis in patients with chronic liver disease, although no useful strategy for improving muscle volume and strength has been established." | 1.46 | Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. ( Abe, M; Aibiki, T; Hiasa, Y; Hiraoka, A; Hirooka, M; Iwasaki, R; Izumoto, H; Kaneto, M; Kiguchi, D; Kishida, M; Kitahata, S; Kohgami, S; Matsuura, B; Michitaka, K; Miyamoto, Y; Miyata, H; Mori, K; Ninomiya, T; Okudaira, T; Suga, Y; Tokumoto, Y; Tomida, H; Tsubouchi, E; Ueki, H; Yamago, H, 2017) |
| "Hyperammonemia is a consistent abnormality in cirrhosis that results in impaired skeletal muscle protein synthesis and breakdown (proteostasis)." | 1.46 | Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis. ( Dasarathy, S; Davuluri, G; Deutz, NEP; Engelen, MPKJ; Kumar, A; Prayson, R; Silva, RNE; Ten Have, GAM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Deutsch-Link, S | 1 |
| Moon, AM | 1 |
| Jiang, Y | 1 |
| Barritt, AS | 1 |
| Tapper, EB | 1 |
| Seo, KI | 1 |
| Miramontes, E | 1 |
| Mozdziak, P | 1 |
| Petitte, JN | 1 |
| Kulus, M | 1 |
| Wieczorkiewicz, M | 1 |
| Kempisty, B | 1 |
| Fujita, M | 1 |
| Abe, K | 1 |
| Hayashi, M | 1 |
| Takahashi, A | 1 |
| Ohira, H | 1 |
| Hiraoka, A | 1 |
| Michitaka, K | 1 |
| Kiguchi, D | 1 |
| Izumoto, H | 1 |
| Ueki, H | 1 |
| Kaneto, M | 1 |
| Kitahata, S | 1 |
| Aibiki, T | 1 |
| Okudaira, T | 1 |
| Tomida, H | 1 |
| Miyamoto, Y | 1 |
| Yamago, H | 1 |
| Suga, Y | 1 |
| Iwasaki, R | 1 |
| Mori, K | 1 |
| Miyata, H | 1 |
| Tsubouchi, E | 1 |
| Kishida, M | 1 |
| Ninomiya, T | 1 |
| Kohgami, S | 1 |
| Hirooka, M | 1 |
| Tokumoto, Y | 1 |
| Abe, M | 1 |
| Matsuura, B | 1 |
| Hiasa, Y | 1 |
| Bhanji, RA | 1 |
| Moctezuma-Velazquez, C | 1 |
| Duarte-Rojo, A | 1 |
| Ebadi, M | 1 |
| Ghosh, S | 1 |
| Rose, C | 1 |
| Montano-Loza, AJ | 1 |
| Chang, KV | 1 |
| Chen, JD | 1 |
| Wu, WT | 1 |
| Huang, KC | 1 |
| Lin, HY | 1 |
| Han, DS | 1 |
| Gioia, S | 1 |
| Merli, M | 2 |
| Nardelli, S | 1 |
| Lattanzi, B | 2 |
| Pitocchi, F | 1 |
| Ridola, L | 1 |
| Riggio, O | 2 |
| Jindal, A | 1 |
| Jagdish, RK | 1 |
| Butterworth, RF | 1 |
| Lucero, C | 1 |
| Verna, EC | 1 |
| Kumar, A | 1 |
| Davuluri, G | 1 |
| Silva, RNE | 1 |
| Engelen, MPKJ | 1 |
| Ten Have, GAM | 1 |
| Prayson, R | 1 |
| Deutz, NEP | 1 |
| Dasarathy, S | 1 |
| Giusto, M | 1 |
| Lucidi, C | 1 |
| Giannelli, V | 1 |
| Pentassuglio, I | 1 |
| Di Gregorio, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Expanding the Therapeutic Landscape of Post-TIPS Hepatic Encephalopathy[NCT05346029] | 140 participants (Anticipated) | Interventional | 2022-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for ammonium hydroxide and Sarcopenia
| Article | Year |
|---|---|
Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends.
Topics: Adult; Ammonia; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Sarcopenia | 2022 |
[Sarcopenia in Chronic Liver Disease].
Topics: Ammonia; Humans; Liver Diseases; Prognosis; Psoas Muscles; Retrospective Studies; Sarcopenia | 2023 |
Skeletal Muscle and the Effects of Ammonia Toxicity in Fish, Mammalian, and Avian Species: A Comparative Review Based on Molecular Research.
Topics: Ammonia; Animals; Birds; Fishes; Hyperammonemia; Liver Cirrhosis; Mammals; Muscle Development; Muscl | 2020 |
Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis.
Topics: Ammonia; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Muscle, Skeletal; Sarcopenia | 2019 |
Sarcopenia: Ammonia metabolism and hepatic encephalopathy.
Topics: Ammonia; Exercise Therapy; Follistatin; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Muscle Prot | 2019 |
L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle.
Topics: Ammonia; Dipeptides; End Stage Liver Disease; Humans; Hyperammonemia; Liver; Sarcopenia; Treatment O | 2019 |
The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management.
Topics: Ammonia; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Transplantation; Sarcopenia | 2015 |
6 other studies available for ammonium hydroxide and Sarcopenia
| Article | Year |
|---|---|
Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis.
Topics: Adult; Aged; Aged, 80 and over; Ammonia; Carnitine; Female; Humans; Liver Cirrhosis; Male; Middle Ag | 2020 |
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.
Topics: Aged; Amino Acids, Branched-Chain; Ammonia; Body Composition; Dietary Supplements; Exercise Test; Ex | 2017 |
Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Topics: Adipose Tissue; Age Factors; Aged; Ammonia; Canada; Correlation of Data; Female; Hepatic Encephalopa | 2018 |
The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.
Topics: Ammonia; Cognitive Dysfunction; Female; Hepatic Encephalopathy; Humans; Italy; Liver Cirrhosis; Male | 2019 |
Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
Topics: Ammonia; Analysis of Variance; Animals; Autophagy; Disease Models, Animal; Homeostasis; Hyperammonem | 2017 |
Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.
Topics: Aged; Ammonia; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Malnutrition; Middle A | 2013 |